Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1883 1
1884 1
1886 1
1887 1
1890 1
1899 1
1910 1
1912 1
1913 2
1914 1
1916 1
1918 2
1921 1
1928 1
1932 1
1933 1
1934 1
1945 3
1946 11
1947 8
1948 8
1949 9
1950 8
1951 16
1952 8
1953 10
1954 5
1955 8
1956 8
1957 7
1958 5
1959 6
1960 2
1961 10
1962 11
1963 16
1964 10
1965 14
1966 15
1967 5
1968 20
1969 31
1970 26
1971 37
1972 34
1973 31
1974 41
1975 33
1976 29
1977 44
1978 31
1979 35
1980 38
1981 22
1982 43
1983 43
1984 52
1985 40
1986 43
1987 56
1988 43
1989 51
1990 50
1991 45
1992 47
1993 36
1994 49
1995 47
1996 46
1997 47
1998 51
1999 30
2000 49
2001 45
2002 43
2003 32
2004 49
2005 31
2006 37
2007 44
2008 104
2009 112
2010 77
2011 97
2012 83
2013 72
2014 91
2015 92
2016 103
2017 88
2018 97
2019 104
2020 125
2021 128
2022 17
Text availability
Article attribute
Article type
Publication date

Search Results

3,036 results
Results by year
Filters applied: . Clear all
Page 1
Coccidioidomycosis.
Stockamp NW, Thompson GR 3rd. Stockamp NW, et al. Among authors: thompson gr 3rd. Infect Dis Clin North Am. 2016 Mar;30(1):229-46. doi: 10.1016/j.idc.2015.10.008. Epub 2015 Dec 29. Infect Dis Clin North Am. 2016. PMID: 26739609 Review.
Aspergillus Infections.
Thompson GR 3rd, Young JH. Thompson GR 3rd, et al. N Engl J Med. 2021 Oct 14;385(16):1496-1509. doi: 10.1056/NEJMra2027424. N Engl J Med. 2021. PMID: 34644473 Review. No abstract available.
Aspergillosis: Epidemiology, Diagnosis, and Treatment.
Cadena J, Thompson GR 3rd, Patterson TF. Cadena J, et al. Among authors: thompson gr 3rd. Infect Dis Clin North Am. 2021 Jun;35(2):415-434. doi: 10.1016/j.idc.2021.03.008. Infect Dis Clin North Am. 2021. PMID: 34016284 Review.
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.
Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, Cruciani M, Cuenca-Estrella M, Decker CF, Desai SR, Fisher B, Harrison T, Heussel CP, Jensen HE, Kibbler CC, Kontoyiannis DP, Kullberg BJ, Lagrou K, Lamoth F, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Marchetti O, Marr KA, Masur H, Meis JF, Morrisey CO, Nucci M, Ostrosky-Zeichner L, Pagano L, Patterson TF, Perfect JR, Racil Z, Roilides E, Ruhnke M, Prokop CS, Shoham S, Slavin MA, Stevens DA, Thompson GR, Vazquez JA, Viscoli C, Walsh TJ, Warris A, Wheat LJ, White PL, Zaoutis TE, Pappas PG. Donnelly JP, et al. Among authors: thompson gr. Clin Infect Dis. 2020 Sep 12;71(6):1367-1376. doi: 10.1093/cid/ciz1008. Clin Infect Dis. 2020. PMID: 31802125 Free PMC article.
Breakthrough invasive fungal infections: Who is at risk?
Jenks JD, Cornely OA, Chen SC, Thompson GR 3rd, Hoenigl M. Jenks JD, et al. Among authors: thompson gr 3rd. Mycoses. 2020 Oct;63(10):1021-1032. doi: 10.1111/myc.13148. Epub 2020 Sep 4. Mycoses. 2020. PMID: 32744334 Review.
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ. Maertens JA, et al. Among authors: thompson gr 3rd. Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10. Lancet. 2016. PMID: 26684607 Clinical Trial.
Ibrexafungerp: A novel oral glucan synthase inhibitor.
Davis MR, Donnelley MA, Thompson GR. Davis MR, et al. Among authors: thompson gr. Med Mycol. 2020 Jul 1;58(5):579-592. doi: 10.1093/mmy/myz083. Med Mycol. 2020. PMID: 31342066 Review.
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3rd, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JH, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, Vehreschild MJGT; VITAL and FungiScope Mucormycosis Investigators. Marty FM, et al. Among authors: thompson gr 3rd. Lancet Infect Dis. 2016 Jul;16(7):828-837. doi: 10.1016/S1473-3099(16)00071-2. Epub 2016 Mar 9. Lancet Infect Dis. 2016. PMID: 26969258 Clinical Trial.
Effect of Nebulized Magnesium vs Placebo Added to Albuterol on Hospitalization Among Children With Refractory Acute Asthma Treated in the Emergency Department: A Randomized Clinical Trial.
Schuh S, Sweeney J, Rumantir M, Coates AL, Willan AR, Stephens D, Atenafu EG, Finkelstein Y, Thompson G, Zemek R, Plint AC, Gravel J, Ducharme FM, Johnson DW, Black K, Curtis S, Beer D, Klassen TP, Nicksy D, Freedman SB; Pediatric Emergency Research Canada (PERC) Network. Schuh S, et al. Among authors: thompson g. JAMA. 2020 Nov 24;324(20):2038-2047. doi: 10.1001/jama.2020.19839. JAMA. 2020. PMID: 33231663 Free PMC article. Clinical Trial.
3,036 results